REPORT ID 2710

United States Follicle-stimulating Hormone (FSH) Market Report 2017

Publish Date
11-Dec-17
Pages
101
Format
Electronic (PDF)

In this report, the United States Follicle-stimulating Hormone (FSH) market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Follicle-stimulating Hormone (FSH) in these regions, from 2012 to 2022 (forecast).

United States Follicle-stimulating Hormone (FSH) market competition by top manufacturers/players, with Follicle-stimulating Hormone (FSH) sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Merck Serono
    MSD
    IBSA
    Ferring
    Livzon
    Techwell
    GenSci
    ...

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Recombinant FSH
    Urinary FSH
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Infertility Treatment
    Assisted Reproductive Technology

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Follicle-stimulating Hormone (FSH) Market Report 2017
1 Follicle-stimulating Hormone (FSH) Overview
    1.1 Product Overview and Scope of Follicle-stimulating Hormone (FSH)
    1.2 Classification of Follicle-stimulating Hormone (FSH) by Product Category
        1.2.1 United States Follicle-stimulating Hormone (FSH) Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Follicle-stimulating Hormone (FSH) Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 Recombinant FSH
        1.2.4 Urinary FSH
    1.3 United States Follicle-stimulating Hormone (FSH) Market by Application/End Users
        1.3.1 United States Follicle-stimulating Hormone (FSH) Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Infertility Treatment
        1.3.3 Assisted Reproductive Technology
    1.4 United States Follicle-stimulating Hormone (FSH) Market by Region
        1.4.1 United States Follicle-stimulating Hormone (FSH) Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Follicle-stimulating Hormone (FSH) Status and Prospect (2012-2022)
        1.4.3 Southwest Follicle-stimulating Hormone (FSH) Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Follicle-stimulating Hormone (FSH) Status and Prospect (2012-2022)
        1.4.5 New England Follicle-stimulating Hormone (FSH) Status and Prospect (2012-2022)
        1.4.6 The South Follicle-stimulating Hormone (FSH) Status and Prospect (2012-2022)
        1.4.7 The Midwest Follicle-stimulating Hormone (FSH) Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Follicle-stimulating Hormone (FSH) (2012-2022)
        1.5.1 United States Follicle-stimulating Hormone (FSH) Sales and Growth Rate (2012-2022)
        1.5.2 United States Follicle-stimulating Hormone (FSH) Revenue and Growth Rate (2012-2022)

2 United States Follicle-stimulating Hormone (FSH) Market Competition by Players/Suppliers
    2.1 United States Follicle-stimulating Hormone (FSH) Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Follicle-stimulating Hormone (FSH) Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Follicle-stimulating Hormone (FSH) Average Price by Players/Suppliers (2012-2017)
    2.4 United States Follicle-stimulating Hormone (FSH) Market Competitive Situation and Trends
        2.4.1 United States Follicle-stimulating Hormone (FSH) Market Concentration Rate
        2.4.2 United States Follicle-stimulating Hormone (FSH) Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Follicle-stimulating Hormone (FSH) Manufacturing Base Distribution, Sales Area, Product Type

3 United States Follicle-stimulating Hormone (FSH) Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Follicle-stimulating Hormone (FSH) Sales and Market Share by Region (2012-2017)
    3.2 United States Follicle-stimulating Hormone (FSH) Revenue and Market Share by Region (2012-2017)
    3.3 United States Follicle-stimulating Hormone (FSH) Price by Region (2012-2017)

4 United States Follicle-stimulating Hormone (FSH) Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Follicle-stimulating Hormone (FSH) Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Follicle-stimulating Hormone (FSH) Revenue and Market Share by Type (2012-2017)
    4.3 United States Follicle-stimulating Hormone (FSH) Price by Type (2012-2017)
    4.4 United States Follicle-stimulating Hormone (FSH) Sales Growth Rate by Type (2012-2017)

5 United States Follicle-stimulating Hormone (FSH) Sales (Volume) by Application (2012-2017)
    5.1 United States Follicle-stimulating Hormone (FSH) Sales and Market Share by Application (2012-2017)
    5.2 United States Follicle-stimulating Hormone (FSH) Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Follicle-stimulating Hormone (FSH) Players/Suppliers Profiles and Sales Data
    6.1 Merck Serono
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Follicle-stimulating Hormone (FSH) Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Merck Serono Follicle-stimulating Hormone (FSH) Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 MSD
        6.2.2 Follicle-stimulating Hormone (FSH) Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 MSD Follicle-stimulating Hormone (FSH) Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 IBSA
        6.3.2 Follicle-stimulating Hormone (FSH) Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 IBSA Follicle-stimulating Hormone (FSH) Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Ferring
        6.4.2 Follicle-stimulating Hormone (FSH) Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Ferring Follicle-stimulating Hormone (FSH) Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Livzon
        6.5.2 Follicle-stimulating Hormone (FSH) Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Livzon Follicle-stimulating Hormone (FSH) Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Techwell
        6.6.2 Follicle-stimulating Hormone (FSH) Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Techwell Follicle-stimulating Hormone (FSH) Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 GenSci
        6.7.2 Follicle-stimulating Hormone (FSH) Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 GenSci Follicle-stimulating Hormone (FSH) Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    ...

7 Follicle-stimulating Hormone (FSH) Manufacturing Cost Analysis
    7.1 Follicle-stimulating Hormone (FSH) Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Follicle-stimulating Hormone (FSH)

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Follicle-stimulating Hormone (FSH) Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Follicle-stimulating Hormone (FSH) Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Follicle-stimulating Hormone (FSH) Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Follicle-stimulating Hormone (FSH) Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Follicle-stimulating Hormone (FSH) Sales Volume Forecast by Type (2017-2022)
    11.3 United States Follicle-stimulating Hormone (FSH) Sales Volume Forecast by Application (2017-2022)
    11.4 United States Follicle-stimulating Hormone (FSH) Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer